For drug manufacturers striving to simplify raw material selection while satisfying regulatory requirements, our Emprove® Chemicals portfolio contains over 400 pharmaceutical raw materials organized by different levels of risk.
All raw and starting materials are organized into categories to streamline selection, with each product offering the comprehensive, up-to-date documentation you need to navigate regulatory challenges, manage risks, and improve processes.
Critical raw materials used during production processes have no clearly defined regulatory standards or quality requirements, but are coming more and more into regulatory focus. We continue to advance our Emprove® Chemicals portfolio with the recent addition of the Emprove® Evolve product line, providing fit-for-purpose high-quality raw materials for early stage manufacturing applications. As developing regulatory requirements for critical raw materials pose new challenges, we will continue to evolve our offerings to support your quality risk assessment with detailed documentation and supply chain transparency and control.
As part of the Emprove® Program, the complete Emprove® Evolve, Essential, and Expert chemicals portfolio is supported by Emprove® Dossiers. This comprehensive documentation facilitates your qualification, risk assessment, and process optimization efforts.
Supports raw material qualification and speeds up drug filing preparation.
In line with CTD chapter 3 quality (adapted for excipients)
Free of charge*
*The Material Qualification Dossier is free of charge and available on the specific product detail pages of our website after log-in. It can also be downloaded through the Emprove® Suite.
Answers questions during quality risk assessment according to ICH Q9 and EU 2015/C95/02.
Free of Charge*
*The Quality Management Dossier is free of charge and available on the specific product detail pages of our website after log-in. It can also be downloaded through the Emprove® Suite.
**Based on Rx-360 SAQ Module 3
***Available for Emprove® Essential and Emprove® Expert products only, based on long-term stability studies according to ICH Q1A requirements.
Supports process optimization and safety risk assessment activities.
*The Operational Excellence Dossier can be purchased individually on the product detail pages of our website after log-in or unlimited access through our Emprove® Suite Subscription.
Emprove® API products come with the Emprove® API Information Package which supports API qualification and risk assessment. It includes:
We support our partners in their risk assessment efforts by providing detailed information about the applied Quality Management system, the supply chain, extractable data, and data on the stability of a product. To learn more, select any of the criteria below for our Quality & Service Catalog.
Unlock all the benefits of the Emprove® Chemicals portfolio by subscribing to our Emprove® Suite. Available exclusively for subscribers, all dossiers of the entire Emprove® portfolio can be accessed at your convenience.
Webinar: New PDA/IPEC Technical Report on excipient risk assessment – insights for drug product manufacturers
Webinar: BioPhorum Raw Materials Risk Assessments
Webinar: The Emprove® Program – an introduction focusing on the Emprove® Suite and Emprove® Chemicals content
Webinar: New developments of excipient regulations in China
Webinar: Nitrosamines - New Requirements to Evaluate Contamination Risks
White Paper: Identifying Appropriate-quality Raw Materials in an Evolving Regulatory Environment
Risk Mitigation Tool: Support for Biomanufacturing Processes
Brochure: Satisfy your regulatory requirements
To subscribe today, simply complete and submit the reply form below after reading our Emprove® terms and conditions.
To continue reading please sign in or create an account.Don't Have An Account?